Clinical Trial Update: Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AF [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the CardioFocus Endoscopic Ablation System for symptomatic atrial fibrillation has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• CardioFocus Endoscopic Ablation System

Snippet

Sponsor: CardioFocus | Conditions: Paroxysmal Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2016-07-27